-
Kenya's economy faces climate change risks: World Bank
-
Plague was killing hunter-gatherers 5,500 years ago: study
-
Prince Harry and family to visit UK in July: media
-
What happens when the Strait of Hormuz re-opens?
-
US retail sales beat expectations in May as energy costs stay high
-
Spain logs third-warmest year on record in 2025
-
'Heartbreaking': Afghan govt staff abandon smartphones
-
Groundbreaking US astronaut Christina Koch wins top Spanish award
-
BBC eyes compulsory redundancies in cost-cutting drive
-
Sovereignty fears dog AI enthusiasm at France's Vivatech
-
Japan puts the heat on suspected ice cream cartel
-
Sovereignty fears to dog AI enthusiasm at France's Vivatech
-
MEXC May Report: SPACEX Launchpad Oversubscribed 15.5x, US Equity Futures Volume Jumps 85%
-
MEXC Prediction Markets Launches Combo to Enable Multi-Event Combination Trading
-
'We have always won': Ebola pioneer still on front line at 84
-
Trap, neuter, release: Jakarta battles cat-astrophic stray numbers
-
US Fed set to hold rates steady at Warsh's first meeting in charge
-
Spanish actor Javier Bardem leaves his mark on Hollywood Boulevard
-
After three sessions, SpaceX already among world's most valuable companies
-
Surging SpaceX overtakes Amazon to become 5th biggest company
-
BMW downgrades 2026 targets on Mideast war, China woes
-
German court bans McDonald's from making climate claim
-
Campaigners urge G7 chiefs to protect children from AI risks
-
Like father, like son: Prince George to attend Eton College
-
Paris store to part ways with Shein after ownership change
-
US Federal Reserve kicks off first meeting with Warsh as chair
-
How can France-UK mission help reopen Strait of Hormuz?
-
EU to ban plant-based 'steaks' but veggie 'burgers' sizzle on
-
Russian oil producer rations fuel as Ukraine attacks bite
-
EU clears major hurdle on US tariff deal
-
Mideast war peace deal boosts German investor morale
-
Iran says talks on final US deal to begin this week
-
With feasts and music, Kashmiri weddings keep traditions alive
-
French spies drop AI giant Palantir over US overreliance fears
-
India blocks Telegram before retest exam to curb cheating
-
Bank of Japan hikes interest rate to 31-year high
-
Stocks extend rally, oil flat as peace optimism builds
-
Deadline looms for UniCredit's hostile bid for Commerzbank
-
Bank of Japan hikes rate to 31-year high
-
Scientist confronting the rising global threat of mosquitoes
-
India eyes biofertilisers after Mideast war stoked supply fears
-
Most stocks rise, oil flat following peace deal-fuelled rally
-
Toxic 'time bomb' threatens Mekong river basin
-
EU nears finish line on US tariff deal
-
Social networks, online video outweigh traditional media in 2026
-
Trump says Hormuz to 'completely open' after US-Iran peace deal
-
Timeline of Trump-linked resort project in Albania
-
IMF chief warns energy recovery to take time after US-Iran ceasefire
-
Launch 3 Telecom Secures New Lakeland Facility
-
'Start your engines'? Shipping groups wary on Hormuz reopening
Disgraced surgeon on trial in Sweden over windpipe transplants
An Italian doctor who made headlines for pioneering windpipe surgery went on trial in Sweden on Wednesday, charged with assault for performing the experimental procedure.
Paolo Macchiarini won praise in 2011 after claiming to have performed the world's first synthetic trachea transplants using stem cells while he was a surgeon at Stockholm's Karolinska Institute.
The procedure was hailed as a breakthrough in regenerative medicine.
But allegations soon emerged that the risky procedure had been carried out on at least one person who had not been critically ill at the time of the operation.
The 63-year-old appeared in court in a blue suit Wednesday, where he listened to translated audio as prosecutors listed the charges of "aggravated assault" against three patients.
- 'Disregard for science' -
The Karolinska Institute has confirmed that the three individuals have since died, but did not directly link the deaths to the operations.
"Macchiarini has carried out the surgery with complete disregard for science and tried experience," prosecutor Karin Lundstrom-Kron told the court.
As prosecutors presented their case they referenced both external and internal reviews of the case, including one published in 2016 by physician Kjell Asplund, who argued that Macchiarini should never have been employed by Karolinska in the first place.
"It is clear that this method has not worked," prosecutor Jim Westerberg said, adding that Macchiarini had embellished the benefits of the procedure.
Macchiarini, who took notes without showing much emotion, has maintained the operations constituted treatments and not experiments, and denied being criminally responsible.
"He contends that he has performed health care, cured and helped," Macchiarini's lawyer Bjorn Hurtig told AFP during a recess.
The prosecution's presentation of evidence is expected to continue over several days so the defence will likely not be able to present its side until next week.
But Hurtig said they had "high hopes" they would be able to counter the prosecution's evidence.
"There are quite a lot of gaps in that evidence and there is a lot of evidence that we argue are favourable to our view of things," he said.
- Downplayed risks -
In 2013, the Karolinska hospital suspended all transplants and refused to extend Macchiarini's contract as a surgeon.
A year later, several surgeons at the hospital filed a complaint alleging that Macchiarini had downplayed the risks of the procedure.
Macchiarini carried out three surgeries at Karolinska University Hospital in 2011 and 2012, using an artificial windpipe made of plastic and coating it with the patient's own stem cells.
Together with his colleagues, he performed a total of eight such transplants between 2011 and 2014, the five others taking place in Russia.
An external review in 2015 found Macchiarini guilty of research misconduct, but despite sacking him, the Karolinska Institute repeatedly defended him until 2018, when it found him and several other researchers guilty.
The university's principal stepped down over the scandal, as well as a number of other people.
Medical journal The Lancet in 2018 retracted two papers authored by Macchiarini.
The trial, held in the Solna district court near the Karolinska Institute, is scheduled to take place over 13 days.
Ng.A.Adebayo--CPN